This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 1358894 Affects the Way the Body Breaks Down Midazolam
Clinical trial NCT03754959 · COMPLETED
Trial details
- NCT number
- NCT03754959
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2019-07-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.